Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
Mitzner
S
S
Department of Medicine, University of Rostock, Germany.
Stange
J
J
Pichel
K
K
Handschuk
I
I
Korten
G
G
Ehlers
M
M
Schutt
C
C
Schmidt
R
R
D001672:Biocompatible Materials / Q000009:adverse effects; D015314:Dialysis Solutions / Q000009:adverse effects; D004731:Endotoxins / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000276:immunology / Q000628:therapy; D016030:Kidney Transplantation; D007688:Kidneys, Artificial / Q000009:adverse effects; D018950:Lipopolysaccharide Receptors / Q000097:blood*; D008070:Lipopolysaccharides / Q000009:adverse effects; D008567:Membranes, Artificial; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis / Q000009:adverse effects*; D012995:Solubility
D001672:Biocompatible Materials; D015314:Dialysis Solutions; D004731:Endotoxins; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D008567:Membranes, Artificial